SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
American Journal of Lifestyle Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sullivan, K. M .
Right arrow Articles by DeBellis, R. J.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

State of the Art Reviews: Smoking Cessation

A Review of Treatment Considerations

Karyn M . Sullivan, BSc Pharm , MPH

Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts, Karyn.sullivan{at}mcphs.edu

Sheila M. Seed, BSc Pharm , MPH

Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts

Ronald J. DeBellis, PharmD, FCCP

Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts

Smoking cessation continues to be an area of great concern for public health. Smoking status and willingness to quit should be assessed at every patient visit. A variety of nonprescription and prescription pharmacotherapy options exist for those willing to quit. Medications currently approved by the Food and Drug Administration for smoking cessation include nicotine replacement therapy (gum, lozenge, patch, inhaler, and nasal spray), bupropion sustained release, and the newly approved varenicline. Nortriptyline and clonidine are not indicated for smoking cessation but have been used as second-line agents. This review focuses on each treatment option, including precautions, proper dosing and duration, adverse effects, and medication delivery issues. Attention is also given to individual patient considerations such as combination therapy, pregnancy, postcessation weight gain, and effects of cessation on the current medication regimen.

Key Words: smoking cessation • nicotine replacement therapy • bupropion SR • nortriptyline • clonidine • varenicline

American Journal of Lifestyle Medicine, Vol. 1, No. 3, 201-213 (2007)
DOI: 10.1177/1559827606298725
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement